Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

San-Chi Chen

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Medicine|September 17, 2015
Risk of Ischemic Stroke in Patients With Gastric Cancer: A Nationwide Population-Based Cohort StudyAi-Seon Kuan, San-Chi Chen, Chiu-Mei Yeh, et al.
Journal of the National Cancer Institute|November 6, 2015
Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based StudyChung-Jen Teng, Yu-Wen Hu, San-Chi Chen, et al.
Plos One|April 2, 2016
Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in TaiwanChung-Jen Teng, Leh-Kiong Huon, Yu-Wen Hu, et al.
The Oncologist|March 10, 2025
Efficacy of atezolizumab combined with platinum and etoposide in the treatment of extrapulmonary neuroendocrine carcinomaI-Wei Ho, Nai-Jung Chiang, Jiun-I Lai, et al.
Annals of Hepatology|April 26, 2025
Real-world insights into cabozantinib efficacy in hepatocellular carcinoma: Real-world cabozantinib efficacy in HCCKuan-Chang Lai, Te-Lin Hsu, Shih-Yao Lin, et al.
BMC Cancer|February 5, 2025
PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinomaSan-Chi Chen, Hsiang-Ling Ho, Chien-An Liu, et al.
Cancers|January 17, 2020
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular CarcinomaPei-Chang Lee, Yee Chao, Ming-Huang Chen, et al.
Investigational New Drugs|April 28, 2022
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experienceWen-Chi Wu, Tzu-Yuan Lin, Ming-Huang Chen, et al.
Cancers|April 23, 2022
Determinants of Survival and Post-Progression Outcomes by Sorafenib-Regorafenib Sequencing for Unresectable Hepatocellular CarcinomaI-Cheng Lee, Yee Chao, Pei-Chang Lee, et al.
Hepatology International|August 20, 2022
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatmentChing-Tso Chen, Yin-Hsun Feng, Chia-Jui Yen, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Medicine|September 17, 2015
Risk of Ischemic Stroke in Patients With Gastric Cancer: A Nationwide Population-Based Cohort StudyAi-Seon Kuan, San-Chi Chen, Chiu-Mei Yeh, et al.
Journal of the National Cancer Institute|November 6, 2015
Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based StudyChung-Jen Teng, Yu-Wen Hu, San-Chi Chen, et al.
Plos One|April 2, 2016
Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in TaiwanChung-Jen Teng, Leh-Kiong Huon, Yu-Wen Hu, et al.
The Oncologist|March 10, 2025
Efficacy of atezolizumab combined with platinum and etoposide in the treatment of extrapulmonary neuroendocrine carcinomaI-Wei Ho, Nai-Jung Chiang, Jiun-I Lai, et al.
Annals of Hepatology|April 26, 2025
Real-world insights into cabozantinib efficacy in hepatocellular carcinoma: Real-world cabozantinib efficacy in HCCKuan-Chang Lai, Te-Lin Hsu, Shih-Yao Lin, et al.
BMC Cancer|February 5, 2025
PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinomaSan-Chi Chen, Hsiang-Ling Ho, Chien-An Liu, et al.
Cancers|January 17, 2020
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular CarcinomaPei-Chang Lee, Yee Chao, Ming-Huang Chen, et al.
Investigational New Drugs|April 28, 2022
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experienceWen-Chi Wu, Tzu-Yuan Lin, Ming-Huang Chen, et al.
Cancers|April 23, 2022
Determinants of Survival and Post-Progression Outcomes by Sorafenib-Regorafenib Sequencing for Unresectable Hepatocellular CarcinomaI-Cheng Lee, Yee Chao, Pei-Chang Lee, et al.
Hepatology International|August 20, 2022
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatmentChing-Tso Chen, Yin-Hsun Feng, Chia-Jui Yen, et al.
Pageof 7